These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 27988871)

  • 1. Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.
    Coppen EM; Roos RA
    Drugs; 2017 Jan; 77(1):29-46. PubMed ID: 27988871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deutetrabenazine for the treatment of Huntington's chorea.
    Bashir H; Jankovic J
    Expert Rev Neurother; 2018 Aug; 18(8):625-631. PubMed ID: 29996061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.
    Dean M; Sung VW
    Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.
    Heo YA; Scott LJ
    Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic drugs in Huntington's disease.
    Unti E; Mazzucchi S; Palermo G; Bonuccelli U; Ceravolo R
    Expert Rev Neurother; 2017 Mar; 17(3):227-237. PubMed ID: 27534434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State-of-the-art pharmacological approaches to reduce chorea in Huntington's disease.
    Gibson JS; Claassen DO
    Expert Opin Pharmacother; 2021 Jun; 22(8):1015-1024. PubMed ID: 33550875
    [No Abstract]   [Full Text] [Related]  

  • 7. Tetrabenazine Treatment Patterns and Outcomes for Chorea Associated with Huntington Disease: A Retrospective Chart Review.
    Claassen DO; Iyer RG; Shah-Manek B; DiBonaventura M; Abler V; Sung VW
    J Huntingtons Dis; 2018; 7(4):345-353. PubMed ID: 30282372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the pharmacological management of Huntington's disease.
    Frank S; Jankovic J
    Drugs; 2010 Mar; 70(5):561-71. PubMed ID: 20329804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington's disease: a review of clinical trial data.
    Claassen DO; Philbin M; Carroll B
    Expert Opin Pharmacother; 2019 Dec; 20(18):2209-2221. PubMed ID: 31613641
    [No Abstract]   [Full Text] [Related]  

  • 10. Exploring the Role of Deutetrabenazine in the Treatment of Chorea Linked with Huntington's Disease.
    Tripathi S; Sharma Y; Kumar D
    Curr Rev Clin Exp Pharmacol; 2024 Oct; ():. PubMed ID: 39415318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An experimental model for Huntington's chorea?
    Zeef DH; Jahanshahi A; Vlamings R; Casaca-Carreira J; Santegoeds RG; Janssen ML; Oosterloo M; Temel Y
    Behav Brain Res; 2014 Apr; 262():31-4. PubMed ID: 24412685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in the management of Huntington's disease.
    Devadiga SJ; Bharate SS
    Bioorg Chem; 2022 Mar; 120():105642. PubMed ID: 35121553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of the treatment studies in Huntington's disease since 1990.
    Bonelli RM; Hofmann P
    Expert Opin Pharmacother; 2007 Feb; 8(2):141-53. PubMed ID: 17257085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose olanzapine in Huntington's disease.
    Bonelli RM; Niederwieser G; Tribl GG; Költringer P
    Int Clin Psychopharmacol; 2002 Mar; 17(2):91-3. PubMed ID: 11890191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological management of Huntington's disease: an evidence-based review.
    Bonelli RM; Wenning GK
    Curr Pharm Des; 2006; 12(21):2701-20. PubMed ID: 16842168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chorea associated with Huntington's disease: focus on tetrabenazine.
    Setter SM; Neumiller JJ; Dobbins EK; Wood L; Clark J; DuVall CA; Santiago A
    Consult Pharm; 2009 Jul; 24(7):524-37. PubMed ID: 19689181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-World Experience With Deutetrabenazine for Huntington Disease Chorea.
    Curtis K; Sung V
    J Clin Pharmacol; 2024 Feb; 64(2):178-181. PubMed ID: 37565322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Huntington's disease.
    Frank S
    Neurotherapeutics; 2014 Jan; 11(1):153-60. PubMed ID: 24366610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathophysiology and pharmacological treatment of Huntington disease.
    Pidgeon C; Rickards H
    Behav Neurol; 2013; 26(4):245-53. PubMed ID: 22713409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.